These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 30690954

  • 1. [Clinical Efficacy of Radiotherapy in Helicobacter pylori Negative or Unresponsive to Eradication Therapy Primary Gastric Mucosa-Associated Lymphoid Tissue Lymphoma].
    Park BS, Lee SH.
    Korean J Gastroenterol; 2019 Jan 25; 73(1):19-25. PubMed ID: 30690954
    [Abstract] [Full Text] [Related]

  • 2. Treatment outcome for gastric mucosa-associated lymphoid tissue lymphoma according to Helicobacter pylori infection status: a single-center experience.
    Ryu KD, Kim GH, Park SO, Lee KJ, Moon JY, Jeon HK, Baek DH, Lee BE, Song GA.
    Gut Liver; 2014 Jul 25; 8(4):408-14. PubMed ID: 25071906
    [Abstract] [Full Text] [Related]

  • 3. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
    Gong EJ, Ahn JY, Jung HY, Park H, Ko YB, Na HK, Jung KW, Kim do H, Lee JH, Choi KD, Song HJ, Lee GH, Kim JH.
    Gut Liver; 2016 Sep 15; 10(5):706-13. PubMed ID: 27114423
    [Abstract] [Full Text] [Related]

  • 4. Anti-Helicobacter pylori therapy in localized gastric mucosa-associated lymphoid tissue lymphoma: A prospective, nationwide, multicenter study in Japan.
    Sugizaki K, Tari A, Kitadai Y, Oda I, Nakamura S, Yoshino T, Sugiyama T.
    Helicobacter; 2018 Apr 15; 23(2):e12474. PubMed ID: 29504247
    [Abstract] [Full Text] [Related]

  • 5. Outcome of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.
    Sugimoto M, Kajimura M, Shirai N, Furuta T, Kanaoka S, Ikuma M, Sato Y, Hishida A.
    Intern Med; 2006 Apr 15; 45(6):405-9. PubMed ID: 16617193
    [Abstract] [Full Text] [Related]

  • 6. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
    Park SH, Chi HS, Park SJ, Jang S, Park CJ, Huh JR.
    Korean J Lab Med; 2010 Dec 15; 30(6):547-53. PubMed ID: 21157137
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The role of abdominal CT scan as follow-up after complete remission with successful Helicobacter pylori eradication in patients with H. pylori-positive stage I(E1) gastric MALT lymphoma.
    Choi JY, Lee GH, Ahn JY, Kim MY, Lee JH, Choi KS, Kim DH, Choi KD, Song HJ, Jung HY, Kim JH.
    Helicobacter; 2011 Feb 15; 16(1):36-41. PubMed ID: 21241410
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
    Streubel B, Ye H, Du MQ, Isaacson PG, Chott A, Raderer M.
    Oncology; 2004 Feb 15; 66(6):476-80. PubMed ID: 15452377
    [Abstract] [Full Text] [Related]

  • 12. Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy.
    Takigawa H, Yuge R, Masaki S, Otani R, Kadota H, Naito T, Hayashi R, Urabe Y, Oka S, Tanaka S, Chayama K, Kitadai Y.
    Gastric Cancer; 2021 Jul 15; 24(4):937-945. PubMed ID: 33638751
    [Abstract] [Full Text] [Related]

  • 13. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
    Begum S, Sano T, Endo H, Kawamata H, Urakami Y.
    J Med Invest; 2000 Feb 15; 47(1-2):36-46. PubMed ID: 10740978
    [Abstract] [Full Text] [Related]

  • 14. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT, Lin JT, Tai JJ, Chen GH, Yeh HZ, Yang SS, Wang HP, Kuo SH, Sheu BS, Jan CM, Wang WM, Wang TE, Wu CW, Chen CL, Su IJ, Whang-Peng J, Cheng AL.
    J Natl Cancer Inst; 2005 Sep 21; 97(18):1345-53. PubMed ID: 16174856
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
    Nakamura S, Matsumoto T, Suekane H, Nakamura S, Matsumoto H, Esaki M, Yao T, Iida M.
    Cancer; 2005 Aug 01; 104(3):532-40. PubMed ID: 15937928
    [Abstract] [Full Text] [Related]

  • 17. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T, Seto M, Tajika M, Kawai H, Yokoi T, Yatabe Y, Nakamura S.
    Am J Gastroenterol; 2008 Jan 01; 103(1):62-70. PubMed ID: 17894851
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C, Santon A, Boixeda D, Redondo C, Alvarez I, Calleja JL, de Argila CM, Bellas C.
    Haematologica; 2001 Jun 01; 86(6):609-17. PubMed ID: 11418369
    [Abstract] [Full Text] [Related]

  • 20. Eradication therapy is effective for Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma.
    Asano N, Iijima K, Terai S, Jin X, Ara N, Chiba T, Fushiya J, Koike T, Imatani A, Shimosegawa T.
    Tohoku J Exp Med; 2012 Nov 01; 228(3):223-7. PubMed ID: 23076291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.